BDRX
Biodexa Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · GB
$2.69
−4.61%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-46.5%
Return on equity
-35.1%
Return on assets
-99.1%
Return on invested capital
0.00x
Asset turnover
-$9.3M
Cash from operations
$8.21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026